A device that uses a smartphone to deliver electronic pulses to stimulate acute migraine relief received market authorization from the FDA this week, according to Israeli biomedical startup Theranica.
The Nerivio Migra is a wireless device that attaches to a patient's upper arm and administers remote electrical neuromodulation, controlled by the patient's smartphone. A recent study found that when 252 patients used the wearable device to treat migraine attacks, more than 66 percent experienced pain relief within two hours.
As Theranica now prepares to commercialize the Nerivio Migra in the U.S., CEO Alon Ironi said the company will also be continuing to explore the use of the device's non-invasive, drug-free technology to treat "at least 7 different painful conditions."
More articles about health IT:
Harvard Business Review: What boards need to know about AI
ZeOmega AI uses social determinants of health to predict risk of opioid abuse
Wearable neurotech companies need to rein in claims, ethics experts say